TNFSF10 and cancer: By inducing caspase-dependent apoptotic cell death, MSCs-derived exosome harboring TRAIL protein could reduce the survival capacity of several cancer cells, including glioblastoma (163), tongue squamous cell carcinoma (164), myeloma (165), lung cancer (166), Ewing sarcoma (167), and mesothelioma (168).